Regulatory/Legislative News

The FDA has accepted an investigational new drug application for Brimochol, according to a press release from Visus Therapeutics.

The FDA has granted orphan drug designation for chemically induced photoreceptor-like cells to treat retinitis pigmentosa, according to a press release from CiRC Biosciences.

Some currently marketed orbital implants were cleared through equivalence to a later-recalled device, according to a poster at the virtual American Society of Ophthalmic Plastic and Reconstructive Surgery annual meeting.

Compounded off-label glaucoma therapies can reduce medication prices and lead to more widespread treatment, according to a speaker.

President Joseph R. Biden, Jr., is taking executive actions “to restore and strengthen Americans’ access to quality, affordable health care,” according to a statement from the White House.

President Joseph R. Biden Jr. on Jan. 25 issued an executive order that allows transgender men and women to serve in the military again.

Surgeon General Jerome M. Adams, MD, has stepped down from his position after being asked to do so by the staff of President Joseph R. Biden Jr., according to the surgeon general’s Twitter account.

Several pharmacy associations applauded a recent Supreme Court decision regarding how much pharmacy benefit managers reimburse pharmacies for the cost of drugs covered by employer-sponsored health plans.

The Image Quality Analyzer software system received 510(k) clearance from the FDA, VisionQuest Biomedical announced in a press release.

President-elect Joseph R. Biden Jr. announced key members of his health team today — individuals he called “trusted, accomplished” and “ready from day one” to bring the COVID-19 pandemic under control.